How Eden Compares to Sequence by WeightWatchers® for GLP-1 Treatment Options

What Is Eden?

Eden is a telehealth platform that connects individuals with licensed healthcare providers who evaluate eligibility for prescription treatments like semaglutide or tirzepatide. These providers may prescribe GLP-1s for type 2 diabetes or weight management when clinically appropriate.

What sets Eden apart is its straightforward pricing and clinical approach. Eden’s platform does not include weight-loss coaching or fitness programs—instead, it offers direct access to care from licensed healthcare providers. If treatment is appropriate, prescriptions are sent to licensed pharmacies for fulfillment.

‍

What Is Sequence by WeightWatchers®?

Sequence is a subscription-based program offered by WeightWatchers that blends clinical care with lifestyle coaching. After onboarding, members are matched with a care team that may include doctors, dietitians, and fitness coaches. The platform includes the WeightWatchers® app, which focuses on food tracking, activity, and behavioral support.

Like Eden, Sequence also provides access to GLP-1 prescriptions when appropriate. However, its monthly membership fee, which may be higher depending on services selected, includes bundled support for behavior change and long-term lifestyle modification.

‍

Pricing Comparison

‍

‍

Eden’s pricing model is built for flexibility. It does not bundle in lifestyle coaching, which may appeal to individuals who already have fitness routines or prefer to focus on clinical consultations.

‍

Licensed Healthcare Provider Access

Both platforms connect users with licensed healthcare providers for evaluation. On Eden’s platform, providers independently assess each person’s medical history, weight-related concerns, and overall goals. If a prescription is appropriate, the provider may initiate treatment through a licensed pharmacy.

Sequence offers a similar medical review, but also emphasizes health coaching, with support from a care team. While this integrated model may appeal to those seeking additional guidance, some individuals may prefer Eden’s model, which emphasizes provider-led clinical consultations.

Not sure which model is right for you? 

‍

Clinical Criteria and Eligibility

Eligibility for GLP-1 treatment generally depends on health history, BMI, metabolic risk factors, and whether there is a diagnosis of type 2 diabetes or obesity. Providers on the Eden platform evaluate eligibility based on:

• BMI ≥30, or ≥27 with related health conditions
• Lab values, including A1c or fasting glucose
• Medical history and current medications
• Willingness to follow up for monitoring

Eden offers a clinically grounded path that may be ideal for those looking to focus on evidence-based treatment planning. 

‍

Insurance vs. Cash Pay Options

Both Eden and Sequence work with patients who choose to pay out of pocket or use insurance. However, how they manage costs differs:

• Eden: Transparent about separating provider access from medication cost. Insurance may be used at the pharmacy for eligible prescriptions.
• Sequence: Medication cost is not included in membership, and insurance support is offered, though coverage may vary based on individual insurance plans.

For many, this means comparing medication prices at different pharmacies. Eden offers flexibility by allowing patients to work with their pharmacy of choice to explore pricing options., allowing users to explore cost-saving options with their pharmacy of choice.

‍

Treatment Personalization

GLP-1 medications are not one-size-fits-all, and personalization matters. Eden focuses on tailored care through one-on-one consultations with licensed providers. While Sequence includes lifestyle coaching to support change, Eden emphasizes medically guided strategies that adapt to your progress and preferences.

Personalization may include:

• Adjusting medication dosages gradually
• Evaluating lab results and medical history
• Tracking symptom changes and tolerability
• Revisiting care plans if needed

Evidence suggests that individualized care plans can improve outcomes and minimize side effects. Learn more about GLP-1 medications and their effects: Semaglutide research

‍

Medication Access and Fulfillment

Both Eden and Sequence facilitate access to FDA-approved medications like semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®). These medications have been studied for weight-related indications:

• Semaglutide: NEJM study showing participants lost an average of 14.9% of their body weight over 68 weeks 
• Tirzepatide: NEJM study demonstrating dose-dependent weight loss up to 22.5% in people with obesity

Eden collaborates with licensed pharmacies to fulfill prescriptions. Medication availability and cost depend on insurance status and the selected pharmacy.

‍

Who Might Prefer Eden?

Eden may be a strong fit for those who:

• Want a streamlined care experience with clear pricing
• Prefer one-on-one clinical consultations
• Are already working with a nutritionist or fitness coach
• Value transparency in medication and care costs

‍

Who Might Prefer Sequence?

Sequence may appeal to those who:

• Want lifestyle and behavioral coaching in one place
• Are new to structured weight loss programs
• Prefer bundled services with support tools like the WW® app
• Are comfortable with a monthly membership fee that may be higher depending on services selected

‍

Conclusion

When choosing between Eden and Sequence by WeightWatchers®, the right option depends on your personal goals, support preferences, and budget. Eden may offer a streamlined option for accessing care and provider-guided treatment plans. Sequence, meanwhile, offers a broader wellness approach that combines clinical care with lifestyle tools.

Take time to review each option’s features and speak with a licensed provider who can evaluate whether treatment is appropriate based on your individual health profile. Eden may be a good fit for those seeking transparency, flexibility, and provider-led care.

Curious if you're eligible?

‍

Disclaimer

This article is for informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always consult with a licensed healthcare provider before starting any treatment. Eden does not manufacture, compound, or dispense medication. Eden connects users with licensed healthcare providers who determine eligibility and, if appropriate, prescribe through licensed pharmacies. WeightWatchers® and Sequence™ are registered trademarks of WW International, Inc., and are referenced here for comparison purposes only.

‍

‍